Søgeresultater - Sachdev, Pallavi
- Showing 1 - 11 results of 11
-
1
-
2
-
3
Vav3 Mediates Receptor Protein Tyrosine Kinase Signaling, Regulates GTPase Activity, Modulates Cell Morphology, and Induces Cell Transformation af Zeng, Liyu, Sachdev, Pallavi, Yan, Lunbiao, Chan, Joseph L., Trenkle, Thomas, McClelland, Michael, Welsh, John, Wang, Lu-Hai
Udgivet 2000Text -
4
G protein βγ subunit interaction with the dynein light-chain component Tctex-1 regulates neurite outgrowth af Sachdev, Pallavi, Menon, Santosh, Kastner, David B, Chuang, Jen-Zen, Yeh, Ting-Yu, Conde, Cecilia, Caceres, Alfredo, Sung, Ching-Hwa, Sakmar, Thomas P
Udgivet 2007Text -
5
Correlative serum biomarker analyses in the phase 2 trial of lenvatinib-plus-everolimus in patients with metastatic renal cell carcinoma af Lee, Chung-Han, Motzer, Robert J., Glen, Hilary, Michaelson, M. D., Larkin, James, Minoshima, Yukinori, Kanekiyo, Michio, Ikezawa, Hiroki, Sachdev, Pallavi, Dutcus, Corina E., Funahashi, Yasuhiro, Voss, Martin H.
Udgivet 2020Text -
6
First-in-human study of the PARP/tankyrase inhibitor E7449 in patients with advanced solid tumours and evaluation of a novel drug-response predictor af Plummer, Ruth, Dua, Divyanshu, Cresti, Nicola, Drew, Yvette, Stephens, Peter, Foegh, Marie, Knudsen, Steen, Sachdev, Pallavi, Mistry, Bipin M., Dixit, Vaishali, McGonigle, Sharon, Hall, Nancy, Matijevic, Mark, McGrath, Shannon, Sarker, Debashis
Udgivet 2020Text -
7
Discovery of a CXCR4 agonist pepducin that mobilizes bone marrow hematopoietic cells af Tchernychev, Boris, Ren, Yong, Sachdev, Pallavi, Janz, Jay M., Haggis, Lynn, O'Shea, Adam, McBride, Ed, Looby, Richard, Deng, Qing, McMurry, Thomas, Kazmi, Manija A., Sakmar, Thomas P., Hunt, Stephen, Carlson, Kenneth E.
Udgivet 2010Text -
8
Phase I dose-escalation study of the multikinase inhibitor lenvatinib in patients with advanced solid tumors and in an expanded cohort of patients with melanoma af Hong, David S., Kurzrock, Razelle, Wheler, Jennifer J., Naing, Aung, Falchook, Gerald S., Fu, Siqing, Kim, Kevin B., Davies, Michael A., Nguyen, Ly M., George, Goldy C., Xu, Lucy, Shumaker, Robert, Ren, Min, Mink, Jennifer, Bedell, Cynthia, Andresen, Corina, Sachdev, Pallavi, O'Brien, James P., Nemunaitis, John
Udgivet 2015Text -
9
Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer af Makker, Vicky, Taylor, Matthew H., Aghajanian, Carol, Oaknin, Ana, Mier, James, Cohn, Allen L., Romeo, Margarita, Bratos, Raquel, Brose, Marcia S., DiSimone, Christopher, Messing, Mark, Stepan, Daniel E., Dutcus, Corina E., Wu, Jane, Schmidt, Emmett V., Orlowski, Robert, Sachdev, Pallavi, Shumaker, Robert, Casado Herraez, Antonio
Udgivet 2020Text -
10
First-in-human phase I study of immunomodulatory E7046, an antagonist of PGE(2)-receptor E-type 4 (EP4), in patients with advanced cancers af Hong, David S, Parikh, Aparna, Shapiro, Geoffrey I, Varga, Andrea, Naing, Aung, Meric-Bernstam, Funda, Ataman, Özlem, Reyderman, Larisa, Binder, Terri A, Ren, Min, Liu, Mingjie, Dayal, Satish, Siu, Amy Y, Sachdev, Pallavi, Xu, Lucy, Bhagawati-Prasad, Vijay, Tchakov, Ilian, Ooi, Chean Eng, Bao, Xingfeng, Marabelle, Aurelien
Udgivet 2020Text -
11
High response rate and durability driven by HLA genetic diversity in kidney cancer patients treated with the immunotherapy combination lenvatinib and pembrolizumab. af Lee, Chung-Han, DiNatale, Renzo G., Chowell, Diego, Krishna, Chirag, Makarov, Vladimir, Valero, Cristina, Vuong, Lynda, Lee, Mark, Weiss, Kate, Hoen, Doug, Morris, Luc, Reznik, Ed, Murray, Samuel, Kotecha, Ritesh, Voss, Martin H., Carlo, Maria I, Feldman, Darren, Sachdev, Pallavi, Adachi, Yusuke, Minoshima, Yukinori, Matsui, Junji, Funahashi, Yasuhiro, Nomoto, Kenichi, Hakimi, A. Ari, Motzer, Robert J., Chan, Timothy A.
Udgivet 2021Text